Point-Counterpoint: Piperacillin-Tazobactam Should Be Used to Treat Infections With ESBL-positive Organisms

Journal of Clinical Microbiology - United States
doi 10.1128/jcm.01917-17
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

American Society for Microbiology

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy